½ÃÀ庸°í¼­
»óǰÄÚµå
1593925

ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀå : ±â¼ú, ÀûÀÀÁõ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Magnetic Resonance Angiography Market by Technique (Contrast Enhanced MRA, Non-Contrast Enhanced MRA), Indication (Abdomen, Lower Extremities), End-user - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀåÀº 2023³â¿¡ 29¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 32¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 11.00%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 60¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ(MRA)´Â µ¿¸Æ·ù, ¸·Èû, Ç÷°ü ±âÇü µîÀÇ »óŸ¦ Áø´ÜÇÏ°í Æò°¡Çϱâ À§ÇØ Ç÷°üÀ» ½Ã°¢È­ÇÏ´Â µ¥ »ç¿ëµÇ´Â ºñħ½ÀÀû ¿µ»ó ±â¼úÀÔ´Ï´Ù. MRA´Â Àü¸®¹æ»ç¼±À» ÇÊ¿ä·Î ÇÏÁö ¾Ê°í Á¤È®ÇÑ ¿µ»óÀ» Á¦°øÇÒ ¼ö ÀÖ¾î ºó¹øÇÑ ¸ð´ÏÅ͸µ¿¡ ÀûÇÕÇϸç, ¼øÈ¯±â³»°ú, ½Å°æ°ú, ¿µ»óÀÇÇаú µî ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡ Àû¿ëµÇ°í ÀÖÀ¸¸ç, º´¿ø, ¿µ»óÁø´Ü¼¾ÅÍ, ¿¬±¸±â°ü µî¿¡¼­ ÃÖÁ¾ÀûÀ¸·Î ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Áõ°¡, MRI ±â¼úÀÇ ¹ßÀü, ºñħ½ÀÀû ¿µ»óÁø´Ü¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â Áúº´ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ½ÅÈï±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ºñÁî´Ï½º ±âȸ´Â ÀΰøÁö´É(AI)À» ÅëÇÕÇØ ¿µ»ó ºÐ¼®À» °³¼±Çϰí, MRA ±â¼úÀ» °­È­ÇØ º¸´Ù ºü¸£°í »ó¼¼ÇÑ ¿µ»ó Áø´ÜÀ» Á¦°øÇÏ´Â µ¥ ÀÖ½À´Ï´Ù. ±â¾÷µéÀº AI ±â¹Ý Áø´Ü µµ±¸ °³¹ß¿¡ ÅõÀÚÇϰí ÀÇ·á ½Ã¼³°ú Çù·ÂÇÏ¿© ÀÌ·¯ÇÑ ±â¼úÀ» ÅëÇÕÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª MR ÀåºñÀÇ ³ôÀº ºñ¿ë, ¼÷·ÃµÈ ÀηÂÀÇ Çʿ伺, ÀÓÇöõÆ® ¹× ÁßÁõ Æó¼Ò°øÆ÷Áõ ȯÀÚ¸¦ ¿µ»óÈ­ÇÒ ¶§ ¹ß»ýÇÒ ¼ö ÀÖ´Â ÀáÀçÀû ¹®Á¦ µîÀÇ Á¦¾àÀÌ ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á¿ë À̹Ì¡ÀÇ ±ÔÁ¦¿Í ÀϺΠÁö¿ª¿¡¼­ÀÇ »óȯ ¹®Á¦µµ Ãß°¡ÀûÀÎ Àå¾Ö¹°ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Çõ½ÅÀ» ÃËÁøÇϱâ À§ÇØ ±â¾÷µéÀº ÈÞ´ë¿ë MRA Àåºñ °³¹ß, ¿µ»ó ó¸® ÇÁ·Î¼¼½º È¿À²È­, ȯÀÚ À§ÇèÀ» ÁÙÀÌ´Â Á¶¿µÁ¦¸¦ »ç¿ëÇÏÁö ¾Ê´Â MRA ±â¼ú µîÀÇ Çõ½Å¿¡ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ±â¼ú ¹ßÀü°ú Á¤¹Ð Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¿ªµ¿ÀûÀ¸·Î ¿òÁ÷À̰í ÀÖÀ¸¸ç, ±âÁ¸ À庮À» ÇØ°áÇÏ°í ½ÃÀå ħÅõ¸¦ ³ôÀ̱â À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß ³ë·ÂÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 29¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 32¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 60¾ï 8,000¸¸ ´Þ·¯
CAGR(%) 11.00%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÚ±â°ø¸í Ç÷°üÁ¶¿µÀåÄ¡ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³ëÀÎ Àα¸ Áõ°¡¿Í ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü »ó½Â
    • º¸Çè Àû¿ë °³¼±
    • Àúħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼ºÇâ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °í°¡ÀÇ Àåºñ ºñ¿ë°ú °Ë»ç¿¡ µû¸¥ À§Çè°ú ÇÕº´Áõ
  • ½ÃÀå ±âȸ
    • AI ±â¹Ý À̹ÌÁö ¼Ö·ç¼Ç ¼Ò°³
    • MRA ±â¼ú Çõ½Å
  • ½ÃÀå °úÁ¦
    • °¢±¹ÀÇ ±ÔÁ¦ ½Ã³ª¸®¿À º¯È­

Porter's Five Forces Àڱ⠰ø¸í Ç÷°ü Á¶¿µ ÀåÄ¡ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀå¿¡¼­ÀÇ °æÀï»óȲ ÆÄ¾Ç

ÀÚ±â°ø¸í Ç÷°üÁ¶¿µÀåÄ¡ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÀÚ±â°ø¸í Ç÷°üÁ¶¿µÀåÄ¡ ½ÃÀå¿¡¼­ÀÇ ¾÷üº° ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

ÀÚ±â°ø¸í Ç÷°üÁ¶¿µÀåÄ¡ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ´Þ¼ºÇÒ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀå : ±â¼úº°

  • Á¶¿µ MRA
  • ºñÁ¶¿µ MRA

Á¦7Àå ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀå : ÀûÀÀÁõº°

  • º¹ºÎ
  • ÇÏÁö

Á¦8Àå ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • º´¿ø
  • ¿µ»ó¼¾ÅÍ

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ Àåºñ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Alltech Medical Systems America, Inc.
  • ASG Superconductors SpA
  • Canon, Inc.
  • CentraCare Health System, Inc.
  • Esaote SpA
  • Fairfax Radiology
  • General Electric Company
  • Hitachi, Ltd.
  • Hunt Regional Healthcare
  • Koninklijke Philips N.V.
  • Neusoft Corporation
  • Qscan Services Pty Ltd.
  • Shenzhen Anke High-Tech Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthcare GmbH
LSH

The Magnetic Resonance Angiography Market was valued at USD 2.93 billion in 2023, expected to reach USD 3.23 billion in 2024, and is projected to grow at a CAGR of 11.00%, to USD 6.08 billion by 2030.

Magnetic Resonance Angiography (MRA) is a non-invasive imaging technique used to visualize blood vessels in order to diagnose and evaluate conditions such as aneurysms, blockages, and vascular malformations. It is vital due to its ability to provide precise images without the need for ionizing radiation, making it suitable for frequent monitoring. MRA is applied across a range of medical fields including cardiology, neurology, and radiology, with significant end-use by hospitals, diagnostic imaging centers, and research institutions. The market for MRA is influenced by the growing prevalence of cardiovascular diseases, advancements in MRI technology, and the increasing demand for non-invasive imaging methods. Key growth factors include rising awareness of early disease detection and the expanding healthcare infrastructure in emerging economies. Opportunities within this market lie in the integration of Artificial Intelligence (AI) for improved image analysis, and the enhancement of MRA techniques to provide faster and more detailed imaging. Businesses can capitalize on these opportunities by investing in the development of AI-driven diagnostic tools and collaborating with healthcare facilities to integrate these technologies. However, limitations such as high costs of MR equipment, the need for skilled personnel, and potential challenges in imaging patients with implants or severe claustrophobia can impede growth. Additionally, regulatory challenges in medical imaging and reimbursement issues in some regions present further hurdles. To foster innovation, companies could focus on developing portable MRA devices, improving the efficiency of imaging processes, and innovating in areas like contrast-free MRA techniques to reduce patient risk. The market is dynamic, driven by technological advances and the increasing need for precise diagnostic tools, encouraging continued research and development efforts to address existing barriers and enhance market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 2.93 billion
Estimated Year [2024] USD 3.23 billion
Forecast Year [2030] USD 6.08 billion
CAGR (%) 11.00%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Magnetic Resonance Angiography Market

The Magnetic Resonance Angiography Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population and rising prevalence of cardiovascular diseases
    • Improving insurance coverage
    • Inclination towards minimally invasive procedures
  • Market Restraints
    • High cost of equipment and risk or complications in testing
  • Market Opportunities
    • Introduction AI-based imaging solution
    • Innovation in MRA techniques
  • Market Challenges
    • Changing regulatory scenario across countries

Porter's Five Forces: A Strategic Tool for Navigating the Magnetic Resonance Angiography Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Magnetic Resonance Angiography Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Magnetic Resonance Angiography Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Magnetic Resonance Angiography Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Magnetic Resonance Angiography Market

A detailed market share analysis in the Magnetic Resonance Angiography Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Magnetic Resonance Angiography Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Magnetic Resonance Angiography Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Magnetic Resonance Angiography Market

A strategic analysis of the Magnetic Resonance Angiography Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Magnetic Resonance Angiography Market, highlighting leading vendors and their innovative profiles. These include Alltech Medical Systems America, Inc., ASG Superconductors SpA, Canon, Inc., CentraCare Health System, Inc., Esaote SpA, Fairfax Radiology, General Electric Company, Hitachi, Ltd., Hunt Regional Healthcare, Koninklijke Philips N.V., Neusoft Corporation, Qscan Services Pty Ltd., Shenzhen Anke High-Tech Co., Ltd., Shimadzu Corporation, and Siemens Healthcare GmbH.

Market Segmentation & Coverage

This research report categorizes the Magnetic Resonance Angiography Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technique, market is studied across Contrast Enhanced MRA and Non-Contrast Enhanced MRA.
  • Based on Indication, market is studied across Abdomen and Lower Extremities.
  • Based on End-user, market is studied across Ambulatory Surgical Centers, Hospitals, and Imaging Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population and rising prevalence of cardiovascular diseases
      • 5.1.1.2. Improving insurance coverage
      • 5.1.1.3. Inclination towards minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of equipment and risk or complications in testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction AI-based imaging solution
      • 5.1.3.2. Innovation in MRA techniques
    • 5.1.4. Challenges
      • 5.1.4.1. Changing regulatory scenario across countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Magnetic Resonance Angiography Market, by Technique

  • 6.1. Introduction
  • 6.2. Contrast Enhanced MRA
  • 6.3. Non-Contrast Enhanced MRA

7. Magnetic Resonance Angiography Market, by Indication

  • 7.1. Introduction
  • 7.2. Abdomen
  • 7.3. Lower Extremities

8. Magnetic Resonance Angiography Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Imaging Centers

9. Americas Magnetic Resonance Angiography Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Magnetic Resonance Angiography Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Magnetic Resonance Angiography Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alltech Medical Systems America, Inc.
  • 2. ASG Superconductors SpA
  • 3. Canon, Inc.
  • 4. CentraCare Health System, Inc.
  • 5. Esaote SpA
  • 6. Fairfax Radiology
  • 7. General Electric Company
  • 8. Hitachi, Ltd.
  • 9. Hunt Regional Healthcare
  • 10. Koninklijke Philips N.V.
  • 11. Neusoft Corporation
  • 12. Qscan Services Pty Ltd.
  • 13. Shenzhen Anke High-Tech Co., Ltd.
  • 14. Shimadzu Corporation
  • 15. Siemens Healthcare GmbH
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦